Address
4546 El Camino Real
Mountain View, CA 94022
United States of America (the)
Phone
650 284 4433
Website
Sector
Healthcare
Industry
Biotechnology
Employees
10
First IPO Date
August 26, 2021
| Name | Title | Pay | Year Born |
| Shaun R. Bagai | Chief Executive Officer, Secretary & Director | 814,279 | 1977 |
| Ramtin Agah | Founder, Executive Chairman & Chief Medical Officer | 432,708 | 1966 |
| Ronald Kocak | VP of Finance & Controller | 447,030 | 1958 |
| Leesa Gentry | Chief Clinical Officer | 532,594 | 1970 |
| Mark Voll | CFO & Principal Accounting Officer | 0 | 1955 |
| Robert Strasser | Vice President of Operations and R&D | 0 | N/A |
| Ryan Witt | Senior Vice President and Head of Corporate Strategy & Partnerships | 0 | N/A |
RenovoRx, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing therapies for solid tumor malignancies. The company's primary investigational therapy, RenovoGem, is an innovative drug and device combination. It integrates intra-arterial gemcitabine with the RenovoCath system, currently progressing through pivotal Phase III clinical trials for the treatment of locally advanced pancreatic cancer. Established in 2009, RenovoRx, Inc. maintains its headquarters in Los Altos, California.